Original Article

Dermatologists’ Awareness of and Screening Practices for Hepatitis B Virus Infection Before Initiating Tumor Necrosis Factor-α Inhibitor Therapy

Objective: The aim of the study was to assess dermatologists’ awareness of available guidelines and drug package insert information on the screening for and management of hepatitis B (HBV) infection in patients receiving tumor necrosis factor-α inhibitor (TNF-αI) drug therapies for dermatological disorders. Materials and Methods: An electronic descriptive cross-sectional…